1. ALLA AKTIER
  2. NYHETER
  3. LUMITO

Lumito

Nyheter Lumito Nyheter alla bolag

Successful presence for Lumito at the European Congress of Pathology

Lumito exhibited with a booth at the European Congress of Pathology in Dublin on September 10–12. The congress gathered a total of 4,448 people, and the interest in Lumito's booth was excellent. An increased interest was also shown from repeat visitors and potential distributors.

The European Congress of Pathology ranks as one of Europe's leading congresses in pathology. The congress allows exhibiting companies to present their products and solutions to potential customers and partners.

“The visitors expressed great interest in our product, its technical aspects and when it becomes available on the market. Constructive dialogues have been started for future collaborations, and I am delighted with the response and recognition our unique product has received, especially from visitors from previous congresses", comments Lumitos CEO Mattias Lundin.

During the year, the Company has participated with a booth at three congresses, which has contributed to strengthening the Company's relationship with potential end customers and partners.

For further information, please contact:

Mattias Lundin, CEO Lumito
E-mail: ml@lumito.se
Ph: +46 76 868 45 09 

Lumito

Lumito specialises in medical technology for digital pathology. Through its proprietary and patented technology, Lumito aims to provide healthcare providers with a powerful tool to meet the demands for fast and safe tissue diagnostics in personalised healthcare. The technology enables higher-contrast images without irrelevant background information, making it easier for pathologists to find cancer indications. The technology, based on Up Converting NanoParticles (UCNP), has the potential to significantly improve the diagnosis of tissue samples through higher quality analyses and shortened analysis times. The method has several potential applications, but Lumito has focused primarily on digital pathology and first on a release of SCIZYS by Lumito for use in research laboratories. The company is a spin-off of a research group at the Department of Atomic Physics and Laser Centre. www.lumito.se/en

The share is traded on NGM Nordic SME under the name LUMITO, and Mentor is Mangold Fondkommission.

Image Attachments
Lumito_ECP Congress 2023

Attachments
Successful presence for Lumito at the European Congress of Pathology

Datum 2023-09-21, kl 09:00
Källa MFN
Bifogade filer
Successful presence for Lumito at the European Congress of Pathology
Lumito_​ECP Congress 2023
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!